We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
HER‐2‐Targeted Boron Neutron Capture Therapy with Carborane‐integrated Immunoliposomes Prepared via an Exchanging Reaction.
- Authors
Kawasaki, Riku; Oshige, Ayano; Yamana, Keita; Hirano, Hidetoshi; Nishimura, Kotaro; Miura, Yamato; Yorioka, Ryuji; Sanada, Yu; Bando, Kaori; Tabata, Anri; Yasuhara, Kazuma; Miyazaki, Yusuke; Shinoda, Wataru; Nishimura, Tomoki; Azuma, Hideki; Takata, Takushi; Sakurai, Yoshinori; Tanaka, Hiroki; Suzuki, Minoru; Nagasaki, Takeshi
- Abstract
Boron neutron capture therapy (BNCT) is a promising modality for cancer treatment because of its minimal invasiveness. To maximize the therapeutic benefits of BNCT, the development of efficient platforms for the delivery of boron agents is indispensable. Here, carborane‐integrated immunoliposomes were prepared via an exchanging reaction to achieve HER‐2‐targeted BNCT. The conjugation of an anti‐HER‐2 antibody to carborane‐integrated liposomes successfully endowed these liposomes with targeting properties toward HER‐2‐overexpressing human ovarian cancer cells (SK‐OV3); the resulting BNCT activity toward SK‐OV3 cells obtained using the current immunoliposomal system was 14‐fold that of the l‐BPA/fructose complex, which is a clinically available boron agent. Moreover, the growth of spheroids treated with this system followed by thermal neutron irradiation was significantly suppressed compared with treatment with the l‐BPA/fructose complex.
- Subjects
BORON-neutron capture therapy; NEUTRON capture; EXCHANGE reactions; THERMAL neutrons; NEUTRON irradiation
- Publication
Chemistry - A European Journal, 2023, Vol 29, Issue 72, p1
- ISSN
0947-6539
- Publication type
Article
- DOI
10.1002/chem.202302486